Metoprolol Carinopharm

Metoprolol Tartrate, the active ingredient in Metoprolol Carinopharm, is a beta blocker presented as an injection for intravenous use. It treats hypertension, angina pectoris, acute myocardial infarction, heart failure and cardiac arrhythmias in adult patients.

GNH USA supplies Metoprolol Carinopharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metoprolol Carinopharm is a selective β1‑adrenergic antagonist used in cardiovascular conditions that require rate control or reduced myocardial workload.

Hypertension: lowers systemic blood pressure by decreasing cardiac output. Angina pectoris: reduces myocardial oxygen demand, relieving chest pain. Acute myocardial infarction: improves survival and limits infarct size. Heart failure: decreases heart rate and improves ventricular filling. Cardiac arrhythmias: controls ventricular rate in atrial fibrillation and other supraventricular tachyarrhythmias.

Metoprolol Carinopharm may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Fatigue or weakness - Dizziness or light‑headedness - Bradycardia (slow heart rate) - Cold extremities - Headache - Nausea or mild gastrointestinal upset

Serious or Rare Side Effects: - Severe bradycardia or heart block - Marked hypotension - Bronchospasm, especially in patients with asthma - Allergic reactions such as rash or angioedema - Cardiogenic shock or acute heart failure exacerbation

Before initiating therapy, clinicians should consider several safety measures.

Monitor blood pressure: check regularly to avoid excessive hypotension. Assess heart rate: watch for bradycardia, especially in patients with conduction disorders. Evaluate respiratory status: avoid in severe asthma or COPD where bronchospasm risk is high. Review concomitant medications: be cautious with other AV‑node blockers or calcium channel blockers. Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake the vial.

Metoprolol can interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - Verapamil or diltiazem: combined use may cause profound AV block. - Other β‑blockers: additive bradycardia and hypotension. - Clonidine abrupt withdrawal: may precipitate severe hypertension. - Insulin or oral hypoglycemics: may mask hypoglycemia symptoms.

Moderate Interactions (Monitor Closely): - NSAIDs: may reduce antihypertensive efficacy. - Diuretics: risk of electrolyte disturbances and enhanced hypotensive effect. - Digoxin: may increase serum levels and risk of toxicity. - Selective serotonin reuptake inhibitors: can augment bradycardia.